{
  "ticker": "LGND",
  "company_name": "Ligand Pharmaceuticals Incorporated",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT00938613",
      "title": "Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Seasonal Allergic Rhinitis",
      "start_date": "2007-02",
      "completion_date": "2007-04",
      "enrollment": 0,
      "sponsor": "Ligand Pharmaceuticals"
    },
    {
      "nct_id": "NCT00238628",
      "title": "A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA\u00ae) in the Treatment of Non-Small Cell Lung Cancer",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Lung Cancer",
      "start_date": "2004-04",
      "completion_date": "2005-12",
      "enrollment": 0,
      "sponsor": "Stanford University"
    },
    {
      "nct_id": "NCT04627831",
      "title": "Comparison of Captisol-Enabled\u2122 Iohexol and Omnipaque\u2122 in Patients With Impaired Renal Function Undergoing Coronary Angiography",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Contrast-induced Nephropathy",
      "start_date": "2022-01",
      "completion_date": "2023-04",
      "enrollment": 0,
      "sponsor": "Ligand Pharmaceuticals"
    },
    {
      "nct_id": "NCT02851849",
      "title": "A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Type 2 Diabetes Mellitus",
      "start_date": "2016-09",
      "completion_date": "2017-06",
      "enrollment": 0,
      "sponsor": "Ligand Pharmaceuticals"
    },
    {
      "nct_id": "NCT02250222",
      "title": "Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Type 2 Diabetes Mellitus",
      "start_date": "2014-10",
      "completion_date": "2015-06",
      "enrollment": 0,
      "sponsor": "Ligand Pharmaceuticals"
    },
    {
      "nct_id": "NCT00002439",
      "title": "A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma",
      "status": "COMPLETED",
      "phase": "NA",
      "condition": "Sarcoma, Kaposi, HIV Infections",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Anderson Clinical Research"
    },
    {
      "nct_id": "NCT01128959",
      "title": "Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Epilepsy",
      "start_date": "2010-06",
      "completion_date": "2013-01",
      "enrollment": 0,
      "sponsor": "Lundbeck LLC"
    },
    {
      "nct_id": "NCT00626418",
      "title": "The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Restless Legs Syndrome",
      "start_date": "2008-02",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Ligand Pharmaceuticals"
    },
    {
      "nct_id": "NCT00063076",
      "title": "Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata",
      "status": "COMPLETED",
      "phase": "PHASE2, PHASE3",
      "condition": "Alopecia Areata",
      "start_date": "2003-05",
      "completion_date": "2007-05",
      "enrollment": 0,
      "sponsor": "M.D. Anderson Cancer Center"
    },
    {
      "nct_id": "NCT02672839",
      "title": "A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Type 2 Diabetes Mellitus (T2DM)",
      "start_date": "2016-02",
      "completion_date": "2016-05",
      "enrollment": 0,
      "sponsor": "Ligand Pharmaceuticals"
    }
  ],
  "summary": {
    "total_trials": 41,
    "by_phase": {
      "PHASE2": 19,
      "PHASE1, PHASE2": 4,
      "PHASE1": 8,
      "NA": 5,
      "PHASE3": 3,
      "PHASE2, PHASE3": 1,
      "PHASE4": 1
    },
    "by_status": {
      "COMPLETED": 37,
      "WITHDRAWN": 2,
      "TERMINATED": 2
    },
    "active_trials": 0,
    "completed_trials": 37,
    "conditions": [
      "Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)",
      "Alopecia Areata",
      "Bioequivalence",
      "Bone Loss",
      "Breast Cancer",
      "Carcinoma, Non-small-cell Lung",
      "Chronic Hepatitis B",
      "Contrast-induced Nephropathy",
      "Contrast-induced Nephropathy, Coronary Angiography",
      "Cutaneous T-Cell Lymphoma",
      "Drug/Agent Toxicity by Tissue/Organ, Lymphoma",
      "Early Stage Parkinson's Disease",
      "Epilepsy",
      "Hepatitis B",
      "Hepatocellular Carcinoma",
      "Hypercholesterolemia",
      "Hypertension",
      "Lung Cancer",
      "Lymphoma, T-Cell, Cutaneous",
      "Osteoporosis",
      "Parapsoriasis",
      "Psoriasis",
      "Restless Legs Syndrome",
      "Sarcoma, Kaposi, HIV Infections",
      "Seasonal Allergic Rhinitis",
      "Sepsis, Septic Shock",
      "Septic Shock",
      "Type 2 Diabetes Mellitus",
      "Type 2 Diabetes Mellitus (T2DM)"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:42.730962",
    "search_query": "Ligand Pharmaceuticals Incorporated",
    "url": "https://clinicaltrials.gov/search?term=Ligand+Pharmaceuticals+Incorporated"
  }
}